Video

The Burden of Treatment Resistant Depression

Author(s):

Ryan J. Wakim, MD, DFAPAMerrideth Leggat, MD

Ryan J. Wakim, MD, DFAPA, explores the causes and diagnostic criteria for treatment resistant depression. He also discusses the importance of comprehensive assessment and personalized approaches to care.

Related Videos
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Related Content
Age at Onset Predicts Longevity in Long-Term Care of Schizophrenia | Image Credit: Danie Franco/Unsplash
October 11th 2024

Age at Onset Predicts Longevity in Long-Term Care of Schizophrenia

Connor Iapoce
The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC
January 11th 2024

The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC

Kevin Kunzmann
| Image Credit: Chris Robert/Unsplash
October 10th 2024

Short-Term Surge in Air Pollution May Trigger Schizophrenia Episodes

Connor Iapoce
John J. Miller, MD: A New Era For Psychiatric Medications
August 18th 2022

John J. Miller, MD: A New Era For Psychiatric Medications

Kenny Walter
Aleksi Hamina, PhD | Credit: LinkedIn
October 10th 2024

Paliperidone 3-Month LAI Bests Other Antipsychotics for Preventing Relapse, Treatment Failure in Schizophrenia

Patrick Campbell
Stronger Safety Considerations Needed for Lumateprone Use, Especially for Women
October 10th 2024

Stronger Safety Considerations Needed for Lumateprone Use, Especially for Women

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.